Journal of SAFOMS

Register      Login

VOLUME 7 , ISSUE 2 ( July-December, 2019 ) > List of Articles

Original Article

Evaluation of Efficacy and Safety of Oral Fixed-dose Combination of Probiotics in Bacterial Vaginosis

Arif A Faruqui, Deepti Chitra

Keywords : Bacterial vaginosis, Lactobacillus, Microbiota restoration, Probiotic

Citation Information : Faruqui AA, Chitra D. Evaluation of Efficacy and Safety of Oral Fixed-dose Combination of Probiotics in Bacterial Vaginosis. J South Asian Feder Menopause Soc 2019; 7 (2):62-65.

DOI: 10.5005/jp-journals-10032-1185

License: CC BY-NC 4.0

Published Online: 01-12-2019

Copyright Statement:  Copyright © 2019; The Author(s).


Aim: To evaluate the efficacy and safety of the vaginal-specific lactobacilli strain in management of bacterial vaginosis (BV). Materials and methods: A nonrandomized, open-labeled, noncomparative, multicentric study was conducted in a total of 58 female patients suffering from BV. Each patient was administered a combination of four strains of lactobacilli. Vaginal pH, discharge, odor, itching, and painful urination were performed at baseline, week 2, and week 4 as assessment parameters. Results: At the end of the study, data were extractable in only 56 females (mean age was 34.57 ± 11 years). Associated BV symptoms like vaginal discharge, odor, and painful urination reduced significantly at week 4 as compared to baseline. The most frequently encountered symptoms were vaginal discharge, vaginal pH, odor, and itching. With a shift in pH < 4.5, at the end of week 4 all females showed improvement in the vaginal microbiota. Tolerability of fixed-dose combination was found to be good and none of the subjects discontinued the treatment. Conclusion: Probiotic combination of vaginal-specific probiotic strains was found to be effective and safe for use in females who suffer from BV. Clinical significance: Lactobacilli have been found in very low numbers in women suffering from BV. After supplementing probiotic, mere fall in pH < 4.5 indicates probable colonization of the vagina with a specific strain of lactobacilli has helped in production of lactic acid and restoration of the vaginal microflora.

PDF Share
  1. Vulvovaginal infections; viewed and dated on Feb 21, 2019.
  2. Amit Singh, Vaibhav Kanti, Seema Dayal, et al. Prevalence and risk factors of bacterial vaginosis among women of reproductive age attending rural tertiary care institute of western Uttar Pradesh. J Evolution Med Dent Sci 2016;5(43):2695–2701. DOI: 10.14260/jemds/2016/630.
  3. Bacteria vaginosis (CDC, centers for disease control and prevention); viewed and dated on Feb 21, 2019.
  4. Wilson J. Managing recurrent bacterial vaginosis. Sex Transm Infect 2004;80(1):8–11. DOI: 10.1136/sti.2002.002733.
  5. McClelland RS, Richardson BA, Hassan WM, et al. A prospective study of vaginal bacterial flora and other risk factors for vulvovaginal candidiasis. J Infect Dis 2009;199(12):1883–1890. DOI: 10.1086/599213.
  6. Marschalek J, Farr A, Marie-Louise M, et al. Influence of orally administered probiotic lactobacillus strains on vaginal microbiota in women with breast cancer during chemotherapy: a randomized placebo-controlled double-blinded pilot study. Breast Care (Basel) 2017;12(5):335–339.
  7. Reid G, Bruce AW. Urogenital infections in women: can probiotics help? Postgrad Med J 2003;79(934):428–432. DOI: 10.1136/pmj.79.934.428.
  8. Akgül T, Karakan T. The role of probiotics in women with recurrent urinary tract infections. Turk J Urol 2018;44(5):377–383. DOI: 10.5152/tud.2018.48742.
  9. Redondo-Lopez V, Meriwether C, Schmitt C, et al. Vulvovaginal candidiasis complicating recurrent bacterial vaginosis. Sex Transm Dis 1990;17(1):51–53. DOI: 10.1097/00007435-199001000- 00011.
  10. Swaminathan KR, Devi M, Gerald S, et al. Prevalence of vulvovaginal candidiasis in the women of the reproductive age, in rural India. Int J Clin Obstet Gynae 2017;1(2):37–39.
  11. Gupta V, Nag D, Garg P. Recurrent urinary tract infections in women: how promising is the use of Probiotics? Indian J Med Microbiol 2017;35(3):347–354. DOI: 10.4103/ijmm.IJMM_16_292.
  12. Astarte (HSO Health Care GmbH) Viewed and dated on Feb 21, 2019;
  13. Kaufmann U, Domig KJ, Lippitsch CI, et al. Ability of an orally administered lactobacilli preparation to improve the quality of the neovaginal microflora in male to female transsexual women. Eur J Obstet Gynecol Reprod Biol 2014;172:102–105. DOI: 10.1016/j.ejogrb.2013.10.019.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.